Sleek OTW PTA Dilatation Catheter 426-3022XRecalls & reported problems
Clearstream Technologies Limited · Sleek OTW PTA Dilatation Catheter 3.0mm x 220mm balloon, 150cm shaft · Class 2
All models of Sleek OTW PTA Dilatation Catheter (24)
Data updated Oct 18, 2026 from official FDA records · Editorial policy
- Adverse event reports
- 9
- Deaths reported
- 0
- Injuries reported
- 3
- Recalls naming it
- 0
Summary
The FDA's MAUDE database contains 9 adverse event reports that list this exact device (DI 00801741133787), received between Sep 17, 2018 and Sep 30, 2026 — classified as 3 injuries, 6 malfunctions.
The most frequently reported specific device problem is “Break” (5 reports).
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.
Reports received per month
Most reported problems
Device problems
- Break5
- Deflation Problem4
- Material Deformation4
- Material Rupture3
- Difficult to Open or Remove Packaging Material2
- Device-Device Incompatibility1
- Difficult to Advance1
- Difficult to Remove1
Patient problems
- No Clinical Signs, Symptoms or Conditions6
- No Consequences Or Impact To Patient2
- Appropriate Clinical Signs, Symptoms and Conditions Term/Code Not Available1
- No Patient Involvement1
- Perforation of Vessels1
Recent adverse event reports
The 9 most recent of 9 reports, in the reporter's own words as published by the FDA.
MalfunctionSep 30, 2026Material Rupture
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 50951855 ↗MalfunctionMar 3, 2026Deflation Problem
ON (B)(6) 2026, A PATIENT UNDERWENT A TRANSLUMINAL ANGIOPLASTY OF THE LEFT LOWER LIMB USING THE SLEEK OTW BALLOON. THE BALLOON WAS INFLATED TO SIX ATMOSPHERES FOR A DURATION OF THREE MINUTES. UPON COMPLETION OF THE INFLATION PERIOD, BALLOON DEFLATION WAS ATTEMPTED HOWEVER, INITIAL DEFLATION WAS UNSUCCESSFUL DESPITE MULTIPLE ATTEMPTS. THE PROCEDURE REQUIRED REPLACEMENT OF THE INFLATION DEVICE TO FACILITATE FURTHER DEFLATION EFFORTS. AFTER APPROXIMATELY TEN MINUTES OF TOTAL INFLATION TIME, THE BALLOON WAS SUCCESSFULLY DEFLATED AND REMOVED. THE PROCEDURE WAS COMPLETED. THERE WAS NO REPORTED PATIENT INJURY.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 24494365 ↗MalfunctionJul 31, 2025Break; Packaging Problem; Break; Packaging Problem
ON (B)(6) 2025, DURING A PERIPHERAL VASCULAR ANGIOPLASTY PROCEDURE INVOLVING THE ANTERIOR TIBIAL ARTERY OF THE LOWER LIMB USING A SLEEK OTW PTA CATHETER. PRIOR TO VESSEL INSERTION, IT WAS OBSERVED THAT THE PROTECTIVE PLASTIC WAS ADHERED TO THE BALLOON, CAUSING DETACHMENT FROM THE DEVICE SHAFT AND RENDERING THE CATHETER UNUSABLE. THE PROCEDURE WAS COMPLETED USING ANOTHER DEVICE.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 22673183 ↗InjuryDec 13, 2023Break; Deflation Problem; Difficult to Remove; Material Rupture; Difficult to Open or Remove Packaging Material; Material Deformation; No Apparent Adverse Event; Break; Deflation Problem; Difficult to Remove; Material Rupture; Difficult to Open or Remove Packaging Material; Material Deformation; No Apparent Adverse Event
IT WAS REPORTED THAT DURING PREPARATION OF AN ANGIOPLASTY PROCEDURE, THE BALLOON SLEEVE WAS ALLEGEDLY DIFFICULT TO REMOVE. IT WAS FURTHER REPORTED THAT THE BALLOON ALLEGEDLY WOULDN¿T DEFLATE. THE PROCEDURE WAS COMPLETED USING ANOTHER DEVICE. THERE WAS NO REPORTED PATIENT INJURY.
Patient problems: Appropriate Clinical Signs, Symptoms and Conditions Term/Code Not Available; No Clinical Signs, Symptoms or Conditions
MAUDE report 18316795 ↗MalfunctionDec 10, 2021Break; Difficult to Open or Remove Packaging Material; Break; Difficult to Open or Remove Packaging Material
IT WAS REPORTED THAT DURING PREPARATION OF AN ANGIOPLASTY PROCEDURE, THE BALLOON ALLEGEDLY CAME OFF THE HUB WHILE TRYING TO REMOVE THE PROTECTIVE SLEEVE FROM THE PACKAGED BALLOON. THERE WAS NO PATIENT CONTACT.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 12974578 ↗MalfunctionOct 21, 2020Break; Deflation Problem; Material Rupture; Device-Device Incompatibility; Material Deformation; Break; Deflation Problem; Material Rupture; Device-Device Incompatibility; Material Deformation
THIS REPORT SUMMARIZES ONE MALFUNCTION. A REVIEW OF THE REPORTED INFORMATION INDICATED THAT MODEL 426-3022X PTA BALLOON DILATATION CATHETER ALLEGEDLY EXPERIENCED DEFLATION ISSUE AND BALLOON RUPTURE. THIS INFORMATION WAS RECEIVED FROM ONE SOURCE. THIS MALFUNCTION INVOLVED ONE PATIENT WITH NO CONSEQUENCES. THE PATIENT'S AGE, WEIGHT AND GENDER WERE NOT PROVIDED.
Patient problems: No Clinical Signs, Symptoms or Conditions; No Consequences Or Impact To Patient
MAUDE report 10715186 ↗MalfunctionOct 11, 2019Break; Material Deformation; Break; Material Deformation
THIS REPORT SUMMARIZES ONE MALFUNCTION. A REVIEW OF THE REPORTED INFORMATION INDICATED THAT MODEL 426-3022X PTA BALLOON DILATATION CATHETER ALLEGEDLY EXPERIENCED MATERIAL DEFORMATION AND BREAK. THIS INFORMATION WAS RECEIVED FROM ONE SOURCE. THERE WAS NO PATIENT CONTACT. PATIENT AGE, WEIGHT, AND GENDER WERE NOT PROVIDED.
Patient problems: No Patient Involvement
MAUDE report 9182956 ↗InjuryMar 19, 2019Failure to Advance; Failure to Advance
IT WAS REPORTED THAT THE PTA DILATION CATHETER ALLEGEDLY COULD NOT PASS THE LONG AND HEAVY STENOSIS ANTERIOR TIBIAL ARTERY (ATA) LESION. REPORTEDLY, IMMEDIATELY AFTER THE INFRAPOPLITEAL PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY (IP-PTA), ALLEGEDLY THERE WAS ARTERIAL PERFORATION AND EXCESSIVE BLOOD LOSS. FURTHERMORE, THE PERFORATION WAS TREATED WITH A PROLONGED BALLOON TAMPONADE. THE CURRENT PATIENT STATUS IS UNKNOWN.
Patient problems: Perforation of Vessels
MAUDE report 8433911 ↗InjurySep 17, 2018Deflation Problem; Difficult to Advance; Material Deformation; Deflation Problem; Difficult to Advance; Material Deformation
IT WAS REPORTED THAT DURING TREATMENT IN A CALCIFIED ANTERIOR TIBIAL LESION WITH EIGHTY FIVE PERCENT STENOSIS, THE PTA DILATION CATHETER WAS ALLEGEDLY DIFFICULT TO CROSS THE LESION. IT WAS FURTHER REPORTED THAT AFTER THE HEALTH CARE PROVIDER (HCP) MANAGED TO CROSS THE LESION AND INFLATE THE BALLOON WITHOUT ISSUES, THE BALLOON WAS ALLEGEDLY UNABLE TO DEFLATE WITH AN INFLATION DEVICE OR MULTIPLE SYRINGES. IT WAS ALSO ALLEGED THAT THE HCP PUNCTURED THE BALLOON WITH A 21G NEEDLE STICK THROUGH THE SKIN IN ORDER TO DEFLATE THE BALLOON, REMOVE THE CATHETER FROM THE PATIENT, AND COMPLETE THE PROCEDURE. THE PATIENT WAS HEMODYNAMICALLY STABLE AT THE CONCLUSION OF THE PROCEDURE.
Patient problems: No Consequences Or Impact To Patient
MAUDE report 7882446 ↗
Other Catheter, angioplasty, peripheral, transluminal devices
- Coyote™ ES H74939135152010Boston Scientific Corporation · Catheter, angioplasty, peripheral, transluminal879 reports
- Coyote™ ES H74939135204010Boston Scientific Corporation · Catheter, angioplasty, peripheral, transluminal585 reports
- Coyote™ ES H74939135202010Boston Scientific Corporation · Catheter, angioplasty, peripheral, transluminal437 reports
- Coyote™ ES H74939135304010Boston Scientific Corporation · Catheter, angioplasty, peripheral, transluminal384 reports
- Coyote™ ES H74939135404010Boston Scientific Corporation · Catheter, angioplasty, peripheral, transluminal293 reports
- Coyote™ ES H74939134152010Boston Scientific Corporation · Catheter, angioplasty, peripheral, transluminal279 reports
- Coyote™ H74939185202210Boston Scientific Corporation · Catheter, angioplasty, peripheral, transluminal200 reports
- Coyote™ ES H74939135254010Boston Scientific Corporation · Catheter, angioplasty, peripheral, transluminal127 reports
Sources and updates
- Device record: FDA GUDID, file dated Oct 13, 2026 · View this device in AccessGUDID ↗
- Adverse event reports: FDA MAUDE, file dated Oct 14, 2026 · each report above links to its original FDA record
- Recalls: FDA Medical Device Recalls, file dated Oct 16, 2026
- Page last rebuilt: Oct 18, 2026. Data downloaded through openFDA, which notes it is not validated for clinical or regulatory use.
How reports and recalls are matched · Editorial policy · Report an error on this page